324 related articles for article (PubMed ID: 8757470)
1. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
4. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B
Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical expression of p53 oncoprotein in large bowel adenomas and carcinomas].
Roa JC; Villaseca MA; Roa I; Araya JC; Okayasu I; Flores P; Flores M
Rev Med Chil; 1997 May; 125(5):523-9. PubMed ID: 9497572
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
8. Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia.
Kaklamanis L; Savage A; Mortensen N; Tsiotos P; Doussis-Anagnostopoulou I; Biddolph S; Whitehouse R; Harris AL; Gatter KC
J Pathol; 1996 May; 179(1):10-4. PubMed ID: 8691332
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
[TBL] [Abstract][Full Text] [Related]
10. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
[TBL] [Abstract][Full Text] [Related]
11. The role of bcl-2 in the progression of the colorectal adenoma-carcinoma sequence.
Yang HB; Chow NH; Sheu BS; Chan SH; Chien CH; Su IJ
Anticancer Res; 1999; 19(1B):727-30. PubMed ID: 10216484
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
Han HS; Park YM; Hwang TS
J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
[TBL] [Abstract][Full Text] [Related]
13. Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms.
Kondo E; Miyake T; Shibata M; Kimura T; Iwagaki H; Nakamura S; Tanaka T; Ohara N; Ichimura K; Oka T; Yanai H; Shibasaki F; Yoshino T
Clin Cancer Res; 2005 Oct; 11(20):7255-63. PubMed ID: 16243795
[TBL] [Abstract][Full Text] [Related]
14. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas.
Agui T; McConkey DJ; Tanigawa N
Anticancer Res; 2002; 22(3):1769-76. PubMed ID: 12168867
[TBL] [Abstract][Full Text] [Related]
18. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
[TBL] [Abstract][Full Text] [Related]
20. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
Sundblad AS; Chumbita RL; Zoppi JA
Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
